In researching Emuaid I have found many mixed emotions and was unsure if I wanted to try it or not. One of my HS sites on FB told of an Open Trial they are doing so I called the number today and am now a participant. They will send out my free jar in a few days and then follow up by phone. I'll try FREE. And even if it doesn't work for me I feel like it is a great way to be counted...maybe someone will listen to our suffering.

Emuaid 1-800-881-3900 ask about being a participant for the HS Open Trial.

Tonight on another one of the FB-HS sites the founder of Emuaid posted an apology to HSers. If you haven't seen it CHECK it out below..

My name is Richard Nicolo and I am the founder of Emuaid and the President of Speer Laboratories. I would like to issue a sincere apology to all of the HS sufferers for the various misrepresentations that were erroneously made on behalf of Emuaid in some advertisements and online posts. It was never our intention to marginalize, mischaracterize or harm anyone in this community. Sadly, HS is a misunderstood condition and we as a company failed to fine tune our marketing copy to properly address the facts about HS. By no means did we ever intend to imply that HS is communicable or that it could be cured by our product...we know that it is neither contagious nor curable.

I originally developed this product to treat severe burn victims, however many other uses have been discovered by our customers. The versatility of Emuaid is due in large part to its superior anti-inflammatory properties and its success at reducing pain and infection. Thousands of people living with HS have found Emuaid effective at relieving many of their symptoms. We are often overwhelmed by the success stories HS sufferers report after trying our product. In many cases we don't exactly why it works, just that in certain cases it does. In fact, we are just at the beginning stages of researching the link between Emuaid's action and its efficacy on HS.

I was diagnosed with leukemia 13 years ago and have received multiple treatments over the past 6 years. I know what it is like to live with a chronic disease and I have tremendous compassion for anyone facing an incurable condition. Because of this, I am personally regretful about any negativity our marketing copy has created. We are currently in the process of reviewing all our information related to HS to make sure the facts are correct and delivered succinctly.
In the meantime, I have decided to spearhead a small research trial to better understand the relationship between our product and the symptoms and side effects of HS. This will hopefully serve as the foundation for additional research. Currently, there are 100 openings for people with HS to participate in this study (please contact us at 800-881-3900 for the details).

Ultimately our primary goal is to help people, especially those who have been misdiagnosed, undervalued and underserved by the medical establishment. We do not want to create false hope or make empty promises but rather provide an effective alternative to the current options available to those with HS.

Again, my sincerest apologies,
Richard